Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
How RBI’s gold buying is helping shore up India’s foreign exchange reserves
The Reserve Bank of India has substantially increased its gold reserves, offsetting foreign investment outflows. This aligns with a global trend of central banks accumulating […]
Shah takes ‘kaala chashma’ dig at Rahul’s ‘terrorists saw me’ in Kashmir claim
Union Home Minister Amit Shah criticised Congress leader Rahul Gandhi in the Rajya Sabha, accusing him of ignoring development in Jammu and Kashmir. Shah emphasised […]
Not ‘obliterated’? US intel says Iran can restore nuke sites ‘within months’; contradicts Trump
Conflicting reports emerge regarding the success of US air strikes on Iran’s nuclear program. While President Trump claimed complete obliteration, intelligence assessments suggest key facilities […]